Clinical Review

What to do when a patient presents with breast pain

Author and Disclosure Information

 

References

In summary

Evaluation and counseling for breast pain should be managed by women’s health care providers in a primary care setting. Most patients need reassurance and medical explanation of their symptoms. They should be educated that more than 95% of the time breast pain is not caused by an underlying malignancy but rather due to hormonal and fibrocystic changes, which can be managed conservatively. If the clinical breast examination and recent screening mammogram (in women over age 40) results are negative, patients should be educated that their pain is benign and undergo a trial of conservative measures: wear and sleep in a supporting bra; keep a calendar of symptoms to determine any relation to cyclical changes; and avoid nicotine, caffeine, and fatty food. Topical pain creams with diclofenac and evening primrose oil also can be effective in ameliorating the symptoms. Breast pain is not a surgical disease; referral to a surgical specialist and diagnostic imaging can be unnecessary and expensive.

Pages

Recommended Reading

Soy didn’t up all-cause mortality in breast cancer survivors
MDedge ObGyn
FDA approves third trastuzumab biosimilar
MDedge ObGyn
Therapy ups breast cancer survivors’ cardiac risks
MDedge ObGyn
Anthracycline-free regimen OK in HER2-negative early breast cancer
MDedge ObGyn
FDA approves Tecentriq plus Abraxane in breast cancer
MDedge ObGyn
FDA approves another trastuzumab biosimilar for HER2-positive breast cancer, gastric cancer
MDedge ObGyn
FDA proposes updates to mammography regulations
MDedge ObGyn
ACP: Average-risk women under 50 can postpone mammogram
MDedge ObGyn
FDA approves PI3K inhibitor alpelisib for breast cancer
MDedge ObGyn
Ribociclib/ET improves OS in premenopausal women with HR+/HER2- breast cancer
MDedge ObGyn